Literature DB >> 15078636

Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections.

Dominique Elias1, Olivier Baton, Lucas Sideris, Tadashi Matsuhisa, Marc Pocard, Philippe Lasser.   

Abstract

BACKGROUND: The indications and results of intraoperative radiofrequency ablation (RFA) of liver metastases (LMs) are not well defined in the literature and have never been compared with those of hepatectomy. The aim of the study was to appreciate the local recurrence rate of RFA in comparison with anatomic and wedge resection.
METHODS: Eighty-eight patients with technically unresectable LMs were treated with curative intent. The LMs were treated by anatomic resection (40 patients, 213 LMs) when large, by wedge resection (64 patients, 99 LMs) when peripheral and small, and by RFA (88 patients, 227 LMs) when central and small. The median follow-up was 27.6 months (range, 15-74 months), and a total of 539 LMs were treated (median of 5 per patient).
RESULTS: The local recurrence rates were 5.7% for the 227 RFAs, 7.1% for the 99 wedge resections, and 12.5% for the 40 anatomic resections (P =.216). Local recurrence rates after RFA were correlated with LMs larger than 30 mm (P <.001) and with LMs in direct contact with large vessels (P <.001).
CONCLUSIONS: RFA is as efficient and safe as wedge or anatomic resections in terms of local control.

Entities:  

Mesh:

Year:  2004        PMID: 15078636     DOI: 10.1245/ASO.2004.08.019

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  27 in total

Review 1.  Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies.

Authors:  Gianpiero Gravante; John Overton; Roberto Sorge; Neil Bhardwaj; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-02       Impact factor: 3.452

2.  [Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment].

Authors:  C-T Germer; H J Buhr; C Isbert
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

3.  Experimental hepatic radiofrequency ablation using wet electrodes: electrode-to-vessel distance is a significant predictor for delayed portal vein thrombosis.

Authors:  Lars Frich; Per Kristian Hol; Sumit Roy; Tom Mala; Bjørn Edwin; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Eur Radiol       Date:  2006-03-16       Impact factor: 5.315

4.  Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study.

Authors:  Simeon Niyi Babawale; Thomas Mandøe Jensen; Jens Brøndum Frøkjær
Journal:  World J Gastrointest Surg       Date:  2015-03-27

Review 5.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

6.  Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.

Authors:  Waleed Shady; Elena N Petre; Kinh Gian Do; Mithat Gonen; Hooman Yarmohammadi; Karen T Brown; Nancy E Kemeny; Michael D'Angelica; Peter T Kingham; Stephen B Solomon; Constantinos T Sofocleous
Journal:  J Vasc Interv Radiol       Date:  2017-12-06       Impact factor: 3.464

7.  Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases.

Authors:  Robert M Eisele; Ulf Neumann; Peter Neuhaus; Guido Schumacher
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

8.  Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases.

Authors:  Andrew McKay; Katherine Fradette; Jeremy Lipschitz
Journal:  HPB Surg       Date:  2010-02-01

9.  Role of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation.

Authors:  Jie Wu; Wei Yang; Shanshan Yin; Jinyu Wu; Wei Wu; Kun Yan; Minhua Chen
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

10.  Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.

Authors:  Robert P Jones; Declan Dunne; Paul Sutton; Hassan Z Malik; Stephen W Fenwick; Monica Terlizzo; Elizabeth O'Grady; Claus Koelblinger; Stefan Stättner; Stefan Stremitzer; Thomas Gruenberger; Graeme J Poston
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.